@article{4b6c1f71644844ac92e30b4b49ab76a9,
title = "Phase II trial of neoadjuvant chemotherapy with docetaxel followed by epirubicin in stage II/III breast cancer.",
author = "Bhuvaneswari Ramaswamy and Povoski, \{Steven P.\} and Chris Rhoades and Joan Allen and Marsha Hauger and Donn Young and William Burak and William Farrar and Lisa Yee and Kari Kendra and Sivagurunathan Somasundaram and Sivagurunathan Somasundaram and Orlowski, \{Robert Z.\} and Shapiro, \{Charles L.\}",
note = "Purpose. In most neoadjuvant chemotherapy regimens, the taxane is administered either in combination with an anthracycline or after an anthracycline-containing regimen. We sought to test the feasibility, safety, and determine the pathological complete response (pCR) rate of administering docetaxel first followed by epirubicin as neoadjuvant chemotherapy in women with clinical stage II, III breast cancer.",
year = "2005",
month = sep,
day = "1",
doi = "10.1007/S10549-005-3784-Z",
language = "American English",
volume = "93",
journal = "Breast Cancer Research and Treatment",
issn = "1573-7217",
publisher = "Springer",
number = "1",
}